Nuvation BioNUVB

紐約證券 · USD
6.54
-0.07
(-1.06%)
盤中 09/10 02:34 (UTC+8)
09/10 02:34 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • 0.01
  • 0.01
  • 0.06
  • 0.03
  • 0.05
  • 0.13
  • 0.42
  • 0.83
  • 0.32
icon
  • -
  • -
  • -49.34
  • 685.56
  • -46.00
  • 56.71
  • 171.47
  • 219.09
  • 98.80
  • -61.93
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
31,687
83,228
41,865
13,120
4,833
3,084
5,711
727
1,435
-
營業成本
9,4715,9911,2793,3492,5762,0944,2161,5151,347-
營業毛利
22,216
77,237
40,586
9,771
2,257
990
1,495
-788
88
-
營業費用
73,25273,35674,62366,20565,84659,99455,43747,313470,47320,199
研發費用
30,66135,04734,29728,84627,36224,60129,29927,73129,24712,842
推銷及管理費用
42,59138,30940,32637,35938,48435,39326,13819,58216,1567,357
非經常性項目費用
--------425,070-
其他營業費用
----------
營業利益
-51,036
3,881
-34,037
-56,434
-63,589
-59,004
-53,942
-48,101
-470,385
-20,199
其他收入及費用
-5,0458,2244,1187,1765,0035,8224,5867,0118,0255,407
利息費用
6,7596,7086,6736,5344215489120132-
稅前純益
-62,840
5,397
-36,592
-55,792
-59,007
-53,236
-49,445
-41,210
-462,492
-14,792
所得稅
----------
稅後純益
-62,840
5,397
-36,592
-55,792
-59,007
-53,236
-49,445
-41,210
-462,492
-14,792
基本每股稅後盈餘(元)
-0.180.02-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07
稀釋每股稅後盈餘(元)
-0.180.01-0.11-0.16-0.17-0.16--0.05-1.99-0.07
基本平均股數(千股)
348770.00347332.00344339.00342393.00340746.00338612.00336934.00273565.00244738.00219048.00
稀釋平均股數(千股)
348770.00377521.00344339.00342393.00340746.00338612.00336934.00273565.00244738.00219048.00
還原基本每股稅後盈餘(元)
-0.180.02-0.11-0.16-0.17-0.16-0.15-0.15-1.89-0.07
還原稀釋每股稅後盈餘(元)
-0.180.01-0.11-0.16-0.17-0.16--0.05-1.99-0.07
還原基本平均股數(千股)
348,770347,332344,339342,393340,746338,612336,934273,565244,738219,048
還原稀釋平均股數(千股)
348,770377,521344,339342,393340,746338,612336,934273,565244,738219,048
EBITDA(千元)
-55,90612,123-30,241-49,694-59,547-54,346-50,791-43,030-464,540-17,554

大家都在看

HOT